Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Method optimization for a simultaneous determination of neonicotinoid, carbamate/thiocarbamate, triazole, organophosphate and pyrethroid pesticides and their metabolites in urine using UPLC-MS/MS

  • Bustamante, Carolina M.
  • Bravo, Natalia
  • Ruiz, Paula
  • Grimalt, Joan O.
  • Garí, Mercè
An accurate and sensitive method for the determination of a total of 23 pesticides and their metabolites in human urine has been optimised. The methodology is based on a previously published method based on solid-phase extraction with methanol and acetone followed by ultra-performance liquid chromatography coupled to tandem mass spectrometry (UPLC-MS/MS) in the selected reaction mode (SRM) with both positive and negative electrospray ionization (ESI+/-). The detection settings of the previous method, which allowed to determine the metabolites from 6 organophosphate and 2 pyrethroid pesticides, were optimised in order to include further pesticide groups, such as 11 neonicotinoids, 3 carbamates/thiocarbamates and 2 triazoles. The 5-windows method enduring 22 min was optimized with acceptable results in relation to accuracy (recoveries >75 %), precision (coefficients of variation <26 %) and linearity (R2> 0.9915). The limits of detection ranged between 0.012 ng/mL and 0.058 ng/mL. Samples from the German External Quality Assessment Scheme (G-EQUAS) encompassing 2 pyrethroids, 2 organophosphate and one neonicotinoid (6-chloronicotinic acid, a common metabolite of imidacloprid and acetamiprid) were analysed, and the latter, included in this newest optimization, provided good reference results. The method is optimal as a human biomonitoring tool for health risk assessment in large population surveys., This research has receive financial support from the European Union Projects EDCMET (H2020-HEALTH/0490-825762), NEMESIS (H2020-HEALTH/101137405) and PARC (HEALTH-2021-ENVHLTH-3:101057014) and the Spanish Ministry of Science, Innovation and Universities (CNS2023-143649). Mercè Garí acknowledges the support from the office of the Secretary of Universities and Research and the Ministry of Research and Universities of the Government of Catalonia through the Beatriu de Pinós Programme (Grant No. 2021BP00152). Mercè Garí is currently supported by a fellowship from the Fundación General CSIC's ComFuturo programme which has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No. 101034263. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors are grateful to R. Chaler and A. García Barrera for their support at the Mass Spectrometry Laboratory of IDAEA-CSIC., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

[Dataset] Method optimization for a simultaneous determination of neonicotinoid, carbamate/thiocarbamate, triazole, organophosphate and pyrethroid pesticides and their metabolites in urine using UPLC-MS/MS, Data and R scripts for the manuscript on Pesticides Method Validation

  • Bustamante, Carolina M.
  • Bravo, Natalia
  • Ruiz, Paula
  • Grimalt, Joan O.
  • Garí, Mercè
Data and R scripts for the manuscript on Pesticides Method Validation There are 4 folders with the following contents: LD_Calculations: Contains data and R scripts for the calculation of limits of detection. The R script creates a csv file with the LDs. Precision: Contains data and R scripts for the calculation of intra-day and inter-day precision. The R script creates two csv files with intra-day and inter-day CVs, and graphical representation. <<<<<<< HEAD Linearity_Recovery: Contains data and R scripts for the calculation of R2 as a measure of linearity, as well as graphical visualization of the calibration curves, and calculation of recoveries from QCH and QCL preparations. Matrix_Effects: Contains data, R scripts and graphical representation for the evaluation of matrix effects and recoveries from synthetic/real urine samples. The Figure produced is presented at the manuscript., An accurate and sensitive method for the determination of a total of 23 pesticides and their metabolites in human urine has been optimised. The methodology is based on a previously published method based on solid-phase extraction with methanol and acetone followed by ultra-performance liquid chromatography coupled to tandem mass spectrometry (UPLC-MS/MS) in the selected reaction mode (SRM) with both positive and negative electrospray ionization (ESI+/-). The detection settings of the previous method, which allowed to determine the metabolites from 6 organophosphate and 2 pyrethroid pesticides, were optimised in order to include further pesticide groups, such as 11 neonicotinoids, 3 carbamates/thiocarbamates and 2 triazoles. The 5-windows method enduring 22 min was optimized with acceptable results in relation to accuracy (recoveries >75 %), precision (coefficients of variation <26 %) and linearity (R2> 0.9915). The limits of detection ranged between 0.012 ng/mL and 0.058 ng/mL. Samples from the German External Quality Assessment Scheme (G-EQUAS) encompassing 2 pyrethroids, 2 organophosphate and one neonicotinoid (6-chloronicotinic acid, a common metabolite of imidacloprid and acetamiprid) were analysed, and the latter, included in this newest optimization, provided good reference results. The method is optimal as a human biomonitoring tool for health risk assessment in large population surveys., This research has receive financial support from the European Union Projects EDCMET (H2020-HEALTH/0490-825762), NEMESIS (H2020-HEALTH/101137405) and PARC (HEALTH-2021-ENVHLTH-3:101057014) and the Spanish Ministry of Science, Innovation and Universities (CNS2023-143649). Mercè Garí acknowledges the support from the office of the Secretary of Universities and Research and the Ministry of Research and Universities of the Government of Catalonia through the Beatriu de Pinós Programme (Grant No. 2021BP00152). Mercè Garí is currently supported by a fellowship from the Fundación General CSIC's ComFuturo programme which has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No. 101034263. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors are grateful to R. Chaler and A. García Barrera for their support at the Mass Spectrometry Laboratory of IDAEA-CSIC., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Methodological approach for a simultaneous determination of persistent and non-persistent organic pollutants in human blood (serum/plasma) using gas chromatography and mass spectrometry techniques

  • Bustamante, Carolina M.
  • Ruiz, Paula
  • Rifat, Atiya B.
  • Bravo, Natalia
  • Grimalt, Joan O.
  • Garí, Mercè
Human biomonitoring of persistent organic pollutants (POPs) remains essential for tracking long-term exposure, evaluating health risks, and assessing the effectiveness of regulatory bans. For this purpose, an experimental and analytical methodology has been optimized allowing the determination of 47 POPs, encompassing chlorinated cyclodienes, chlorobenzenes, cyclohexanes, polychlorodiphenyl derivatives, several congeners of polychlorobiphenyls (PCBs) and polybromodiphenyl ethers (PBDEs, including the deca-BDE), as well as three non-persistent chemicals (namely quintozene, tecnazene and vinclozolin). The method uses a single liquid-liquid extraction procedure with 500 µL of serum/plasma. Instrumental analysis involves gas chromatography (GC) with electron capture detection (ECD) for the analysis of organochlorines, and a subsequent injection into a GC coupled to mass spectrometry in negative chemical ionization mode (MS-NCI) for the determination of PBDEs. The analytical procedure has been successfully validated, demonstrating high sensitivity (limits of detection: 0.0016-0.012 ng/mL; limits of quantification: 0.0029-0.021 ng/mL), acceptable linearity (R² > 0.9962), good precision (coefficients of variation <25%, except for BDE-209), satisfactory accuracy (recoveries within 70-130% for 41 out of 47 compounds) and minimal matrix effects. Proficiency Testing Materials from the AMAP Ring Test for POPs in human serum confirmed the method's reliability with results within the accepted reference range. This method represents an efficient and practical approach for human biomonitoring studies, with a simplified workflow suitable for routine application., This study was supported by the Spanish Ministry of Science, Innovation and Universities (ExpoMassDat, CNS2023–143649) and the European Union Projects PARC (HEALTH-2021-ENVHLTH-3:101057014), NEMESIS (HORIZONsingle bondHLTH-2023-ENVHLTH-02–03–101137405) and ENVESOME (HORIZONsingle bondHLTH-2024-ENVHLTH-02–06–101157269). ABR grants the Erasmus Mundus grant of the ECT+ program (SGA 2019–1485). The authors acknowledge BioRender.com for providing the platform and the resources used to create the figures that illustrate the experimental methodologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Unmasking metabolic disruptors: The NEMESIS project's quest for Novel Biomarkers, Evidence on Adverse Effects, and Efficient Methodologies

  • Hakomäki, Henriikka
  • Pitkänen, Sini
  • Levonen, Anna-Liisa
  • Honkakoski, Paavo
  • Greco, Dario
  • D'Alessandro, Nicoletta
  • Saarimäki, Laura Aliisa
  • Viegas, Susana
  • Godinho, Cristina
  • Fyhrquist, Nanna
  • Wincent, Emma
  • Lauschke, Volker M.
  • Hukkanen, Janne
  • Hakkola, Jukka
  • Vallier, Ludovic
  • Fortino, Vittorio
  • Afantitis, Antreas
  • Sawatani, Toshiaki
  • Guzman, Tereso .
  • Cnop, Miriam
  • Nawrot, Tim
  • Harlid, Sophia
  • Vinnars, Marie-Therese
  • Tardon, Adonina
  • Grimalt, Joan O.
  • Küblbeck, Jenni
  • Rysä, Jaana
Metabolism disrupting chemicals (MDCs) elicit negative effects on metabolically active organs such as the liver and the pancreas, altering normal metabolic processes. Chemicals that are known, or suspected MDCs include compounds found in everyday consumer products and food, making low-dose, continuous exposure inevitable for humans. Through the discovery of chemically induced metabolic disruption, a concern has surfaced whether and how MDCs impact human health and the development of metabolic diseases. This has accelerated research around the topic, and it has been found that exposure to MDCs is linked to increased incidence of metabolic diseases including obesity and liver steatosis. Effective regulatory action is hindered by the lack of accurate methods to identify MDCs. The NEMESIS project addresses this regulatory gap by investigating the mechanisms through which MDCs cause metabolic disruption. The project aims at identifying novel biomarkers of exposure and link exposure to disease outcomes. As chemical toxicity testing is rapidly moving towards new approach methodologies (NAMs), NEMESIS promotes non-animal methodologies by employing state-of-the-art in vitro methods, epidemiological data, systems biology approaches, and seeks to replace mammalian in vivo experiments with alternative models. By understanding mechanisms of MDC-induced metabolic health effects, and through the development of reliable effect biomarkers and testing strategies, the NEMESIS project aims to facilitate more effective regulatory measures to improve and protect the health and well-being of EU citizens. The project is particularly focused on maximizing its impact through effective dissemination and communication efforts, to ensure that the project's message and results reach a broad audience and are tailored to different population groups. These actions will improve the risk assessment of MDCs and ensure that the EU citizens are informed and protected from the harmful effects of MDCs and can adapt their consumer patterns and behaviors to prevent exposure., This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No. 101137405 (Novel Effect biomarkers for MEtabolic disruptorS: evidence on health Impacts to answer science and policy needS – NEMESIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., Peer reviewed